Halozyme宣佈，Roche的Ocrevus® Sc與Enhanze®獲得歐洲委員會批

快訊 · 06/25 13:15

Halozyme Announces Roche's Ocrevus® Sc With Enhanze® Receives European Commission Approval for Relapsing and Primary Progressive Multiple Sclerosis

Halozyme宣佈，Roche的Ocrevus® Sc與Enhanze®獲得歐洲委員會批准，用於複發性和初級進行性多發性硬化症。